A Study of KC1036 in Patients with Advanced Solid Tumors

Clinical trial NCT04387916 · RECRUITING

Trial details

NCT number: NCT04387916
Sponsor: Beijing Konruns Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2020-09-04
Primary completion: 2025-10-31
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.